Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study

Saved in:

Bibliographic Details
Main Authors:	Luigi Gargiulo (Author), Luciano Ibba (Author), Matteo Bianco (Author), Sara Di Giulio (Author), Alfano Alfano (Author), Ruggero Cascio Ingurgio (Author), Paola Facheris (Author), Chiara Perugini (Author), Mario Valenti (Author), Antonio Costanzo (Author), Alessandra Narcisi (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000 am a22000003u 4500
001	doaj_aee66e3ca6664bb7a3eec0c55c42c699
042			\|a dc
100	1	0	\|a Luigi Gargiulo \|e author
700	1	0	\|a Luciano Ibba \|e author
700	1	0	\|a Matteo Bianco \|e author
700	1	0	\|a Sara Di Giulio \|e author
700	1	0	\|a Alfano Alfano \|e author
700	1	0	\|a Ruggero Cascio Ingurgio \|e author
700	1	0	\|a Paola Facheris \|e author
700	1	0	\|a Chiara Perugini \|e author
700	1	0	\|a Mario Valenti \|e author
700	1	0	\|a Antonio Costanzo \|e author
700	1	0	\|a Alessandra Narcisi \|e author
245	0	0	\|a Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study
260			\|b Taylor & Francis Group, \|c 2024-12-01T00:00:00Z.
500			\|a 10.1080/09546634.2024.2375102
500			\|a 1471-1753
500			\|a 0954-6634
546			\|a EN
690			\|a Dermatology
690			\|a RL1-803
655	7		\|a article \|2 local
786	0		\|n Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
787	0		\|n https://www.tandfonline.com/doi/10.1080/09546634.2024.2375102
787	0		\|n https://doaj.org/toc/0954-6634
787	0		\|n https://doaj.org/toc/1471-1753
856	4	1	\|u https://doaj.org/article/aee66e3ca6664bb7a3eec0c55c42c699 \|z Connect to this object online.